Introduction
Importing a medical device into Indonesia is not a one-step process. It generally requires two separate approvals: an authorised Indonesian party permitted to import or distribute, and a product-specific authorisation for the device itself.
This guide is for foreign manufacturers, exporters, importers, distributors, and healthcare businesses, including Australian device makers, assessing Indonesia as a market. Without the right licences, shipments stall at customs and lawful distribution cannot start.
Terms such as IDAK, NIE, Izin Edar, Regalkes, and CSDT get thrown around interchangeably, but they apply to different parties or different stages. Indonesia's regulatory framework was overhauled in 2026, so guidance based on older rules needs a fresh look.
Below, we walk through the authorities involved, the licence structure, classification, documentation, the application workflow, common delays, and what happens after approval.
Key Takeaways
- Foreign manufacturers need a local authorised representative, importer, or licensed distributor before commercial import.
- Distributor permission (formerly IDAK) covers the Indonesian entity; NIE/Izin Edar covers each device.
- Risk classification (A–D) determines documentation depth, technical review, and processing time.
- Bahasa Indonesia labelling, CSDT-style dossiers, and post-market controls are mandatory.
- CE marks or FDA clearances can support an application but never replace Indonesian registration.
What Medical Device Import Licences Cover in Indonesia
A "medical device import licence" is a licence stack: one layer covering the local entity's authority to import or distribute, and another covering the specific product's authorisation to be marketed.
Kementerian Kesehatan (Kemenkes), through its Directorate General of Pharmaceuticals and Medical Devices, regulates both layers. Its Regalkes portal handles product-level marketing authorisation applications, while a separate certification portal manages production and distribution licensing for local businesses.
| Layer | Covers | Typical Holder |
|---|---|---|
| Distributor permission (PB Distributor Alat Kesehatan, formerly known as IDAK) | The company's right to distribute devices | Local entity or appointed distributor |
| Product Izin Edar / NIE | The specific device's right to be marketed | Registered on behalf of the manufacturer |
Holding one doesn't automatically satisfy the other. A distributor with a valid permission still can't sell a device that lacks its own Izin Edar. A registered device still can't move through a distributor whose permission has lapsed.
The registration process confirms that the device, manufacturer, labelling, supply chain, and local responsible party all meet Indonesian safety and performance expectations. But it doesn't cover everything:
- Customs clearance and import documentation sit outside product registration.
- Warehousing and distribution require their own facility and personnel standards.
- Advertising claims and post-market surveillance carry separate ongoing obligations.
Treat NIE approval as one milestone among several, not a finish line.
How Medical Device Import Licensing Works: The End-to-End Flow
The path runs from classification through to post-market vigilance. Here's the sequence.
Step 1: Confirm the Product Scope and Classification
Indonesia uses a four-tier risk system — Classes A through D — aligned with the ASEAN Medical Device Directive (AMDD) framework. Classification considers intended use, invasiveness, duration of patient contact, whether the device is active or implantable, and any diagnostic function or special materials involved.
Classification isn't transferable between markets. A device classified as low-risk under the EU MDR or US FDA rules might land in a different Indonesian class depending on how the local classification rules weigh its intended purpose. For example, a wound-contact dressing sold as Class I in one jurisdiction could be assessed differently here if it contains an active ingredient.
Don't copy a classification from another market. Run the device through Indonesia's own classification rules, which are consistent with the ASEAN Medical Device Directive framework, before assembling supporting evidence.
Step 2: Establish the Local Regulatory Route
Two main options exist:
- Appoint a local authorised representative or distributor — faster to set up, but that party may end up holding the NIE and controlling regulatory communication.
- Establish a foreign-owned Indonesian entity (PT PMA) — greater long-term control over registration and distribution, at the cost of incorporation, staffing, and ongoing operational compliance.
Whichever route you choose, the Letter of Authorisation needs to clearly name the manufacturer, the local party, covered products, territory, the scope of authority granted, and its duration. Notarisation, legalisation, or apostille requirements vary by the applicant's home country, so verify this before drafting.
Step 3: Prepare and Submit the Application
Applications go through Regalkes, following administrative review, technical review, and — frequently — deficiency questions from reviewers requiring a documented response before payment and issuance.
In practice, the local party manages the actual Indonesian submission, while the foreign manufacturer supplies the underlying technical, quality, legal, and clinical evidence. This split of responsibility is where miscommunication often causes delays.
Step 4: Import, Distribute, and Maintain Compliance
Approval isn't the end of the process. It needs to be coordinated with:
- Customs documentation and importer-of-record responsibilities
- Compliant packaging and storage conditions
- Distribution, complaint handling, and adverse-event reporting
- Renewal timing and variation applications for any product changes
| Responsibility | Manufacturer | Local Licence Holder | Importer/Distributor |
|---|---|---|---|
| Technical & clinical evidence | ✔ | ||
| Regalkes submission | ✔ | ||
| Customs clearance | ✔ | ||
| Complaint escalation | ✔ | ✔ | ✔ |
Prerequisites and Importer/Representative Options
Before filing anything, the foundation needs to be in place:
- An eligible Indonesian legal entity or local representative
- Relevant business registrations, including the NIB (business identification number)
- Distributor permission and applicable distribution certification
- Suitable facilities, qualified technical personnel, and a documented quality system
Under Indonesia's current distributor standard, a distribution permission application requires premises layout, ownership or lease proof, equipment documentation, and a technical responsible person (PJT) with a documented full-time role.
Facilities and staffing are confirmed after the distributor permission is granted and must match the approved product categories. The distributor must hold its good-distribution-practice certificate before it starts distributing, per Permenkes 11/2025.
You may still see the older acronym "IDAK" or "CDAKB" used in industry conversation. Terminology has shifted with recent regulatory updates, so confirm current naming and requirements directly against Kemenkes sources rather than assuming an older label still applies.
Third-Party Distributor vs PT PMA
| Factor | Third-Party Distributor | PT PMA |
|---|---|---|
| Speed to market | Faster | Slower (requires incorporation) |
| Control over NIE | Often held by distributor | Manufacturer-controlled |
| Ongoing cost | Lower upfront | Higher (staff, facilities, tax) |
| Flexibility to switch partners | Limited | High |
Choosing the wrong local partner creates real operational risk:
- Expired or suspended distributor permission
- Inadequate warehousing for your device categories
- Weak complaint-handling systems
- Disputes over who owns the registered Izin Edar at transfer or renewal
Due-Diligence Checklist for Choosing a Local Partner
- Verify current licence and permission status directly, not by taking their word for it
- Inspect facility readiness and device-category experience
- Review their regulatory track record and distribution network reach
- Confirm technical staff credentials and data-handling practices
- Negotiate audit rights, recall responsibilities, and exit or transfer terms upfront
Documentation, Review, and Ongoing Compliance
Evidence typically falls into distinct groups:
- Corporate and appointment documents
- Manufacturer credentials
- Product and technical information
- Quality and manufacturing evidence
- Clinical or performance data, labelling, and import/distribution records
The CSDT-Style Dossier
Indonesia's dossier structure follows the AMDD's Common Submission Dossier Template logic. Core modules usually include:
- Administrative information, device description, and intended use
- Essential principles, risk management, and verification and validation
- Clinical evidence and manufacturing information
- Labelling and supporting certificates
Commonly requested documents include:
- Letter of Authorisation and Certificate of Free Sale (or equivalent)
- ISO 13485 quality management evidence and manufacturing-site information
- Product specifications, risk analysis, and test reports
- Clinical evaluation data where applicable
- Bahasa Indonesia labelling and instructions for use
Consistency check: Align manufacturer name, legal entity, address, model numbers, product variants, manufacturing sites, certificate scope, dates, signatures, translations, and legalisation status across every file. Mismatches here are one of the most common causes of review delays.
Risk class shapes how deep the technical scrutiny goes, how much clinical evidence is expected, and how many clarification rounds you might face.
Indonesia's product-licensing regulation was reset by Permenkes 5/2026, which revoked the previous 2017 rule many older checklists still reference. Confirm current fee schedules and timelines through the live application rather than a published table.
Special review considerations apply to:
- IVDs and software or SaMD products
- Radiation-emitting devices
- Sterile products and implants
- Devices containing animal-derived materials
Halal Considerations for Animal-Derived Devices
Halal obligations apply specifically to devices originating from animals or containing animal elements — not every device on the market. Published phase-in deadlines differ by risk class:
| Risk Class | Phase-In End Date |
|---|---|
| A | 17 October 2026 |
| B | 17 October 2029 |
| C | 17 October 2034 |
| D | 17 October 2039 |
Screen materials at the ingredient level before assuming certification is or isn't required.
Post-Approval Obligations
Approval triggers a new set of ongoing duties:
- Renew before expiry and file variation applications for relevant product changes
- Maintain complaint and adverse-event reporting processes
- Conduct field safety corrective actions and recalls where necessary
- Keep distribution records current and control advertising claims
- Cooperate with inspections or post-market surveillance requests
Before launch, work through this checklist:
- Confirm local licences are active
- Verify NIE details match your product exactly
- Complete Bahasa Indonesia labelling
- Align customs paperwork
- Establish a local incident-escalation process
Common Issues and When a Route May Not Be Appropriate
Most delays and rejections trace back to a handful of recurring problems:
- Incorrect classification or incomplete CSDT sections
- Inconsistent certificates or unauthorised translations
- Missing legalisation on appointment documents
- Non-compliant labelling or expired local licences
- Slow responses to deficiency requests
A common misconception: an overseas CE mark or FDA clearance doesn't grant automatic Indonesian market access. Foreign approvals can strengthen a technical file, but they don't replace local classification, registration, or labelling requirements.
Two distinct risks often get conflated. A device can hold a perfectly valid Izin Edar while the company importing it operates on an unlicensed or lapsed distributor permission — and that combination still creates a compliance problem.
A third-party distributor may not suit every manufacturer. Consider a different route if you need:
- Multiple distributors operating simultaneously
- Direct, long-term control over the NIE
- Management of a high-value or complex product portfolio
Conversely, setting up a PT PMA can be overkill for a limited market test, a low-volume product, or a manufacturer without the resources to sustain facilities, quality systems, and tax compliance long-term.
Before filing anything, run a gap assessment and build a written responsibility matrix. Don't assume a local partner will quietly absorb technical, customs, or post-market issues after the fact.
Conclusion
Lawful medical device importation into Indonesia comes down to coordinating the local entity or representative's permissions with the product's NIE/Izin Edar approval, then meeting import, labelling, and post-market obligations.
Accurate classification, consistent documentation, and early planning matter far more than the sheer volume of paperwork submitted. Before committing, weigh whether a distributor, an independent licence holder, or a manufacturer-controlled Indonesian entity best fits the level of control and distribution reach you actually need.
If you also need entity formation, accounting, tax, or multi-market compliance planning while pursuing Indonesian medical device registration, VJM Global can support that cross-border business-setup work. Indonesia-specific medical device licensing should always sit with appropriately qualified local regulatory professionals.
Frequently Asked Questions
What are the import restrictions for medical devices in Indonesia?
Commercial importation requires product registration, a compliant Indonesian importer or authorised local party, valid distribution permissions, and correct labelling. Controlled, IVD, and radiation-emitting devices often face additional requirements; verify these against current official sources.
What agency regulates medical devices in Indonesia?
Kementerian Kesehatan (Kemenkes) is the principal regulator through its medical device directorate, with applications processed on the Regalkes portal. Confirm current responsibilities directly with Kemenkes, as terminology has shifted after recent updates.
How long does it take to get Izin Edar approval?
Timelines vary by risk class and documentation completeness. No reliable class-by-class schedule is publicly confirmed after Indonesia's 2026 regulatory reset, so request a live estimate through Regalkes.
Can I use my CE mark or FDA clearance in Indonesia?
Foreign approvals can support your technical file but don't replace Indonesian registration. You'll still need to classify the device locally and complete the full Izin Edar application process.
